Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00091377
Recruitment Status : Completed
First Posted : September 9, 2004
Last Update Posted : July 14, 2016
Information provided by (Responsible Party):
MEI Pharma, Inc.